Bortezomib Accord
Solution for injection
Compare
|
EU/1/15/1019/003-006
Authorised: 23/07/2021
Accord Healthcare S.L.U.
|
SPC
PIL
IPAR
|
Bortezomib Biotech Pharma 3.5 mg powder for solution for injection
Powder for solution for injection
Compare
|
PA25233/001/001
Authorised: 26/06/2020
Target Healthcare Limited
|
SPC
PIL
|
Bortezomib Clonmel 2.5 mg/ml Solution for Injection
Solution for injection
Compare
|
PA0126/297/001
Authorised: 20/04/2018
Clonmel Healthcare Ltd
|
SPC
PIL
|
Bortezomib Fresenius Kabi
Powder for solution for injection
Compare
|
EU/1/19/1397/001
Authorised: 14/11/2019
Fresenius Kabi Deutschland GmbH
|
SPC
PIL
IPAR
|
Bortezomib Hospira
Powder for solution for injection
Compare
|
EU/1/16/1114/001
Authorised: 22/07/2016
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
|
Bortezomib medac 3.5 mg powder for solution for injection
Powder for solution for injection
Compare
|
PA0623/018/001
Authorised: 18/05/2018
medac Gesellschaft für klinische Spezialpräparate mbH
|
SPC
PIL
|
Bortezomib Mylan 3.5 mg powder for solution for injection
Powder for solution for injection
Compare
|
PA0577/191/001
Authorised: 17/05/2019
McDermott Laboratories Ltd., T/A Gerard Laboratories
|
SPC
PIL
|
Bortezomib Rowex 3.5 mg Powder for solution for injection
Powder for solution for injection
Compare
|
PA0711/288/001
Authorised: 13/04/2018
Rowex Ltd
|
SPC
PIL
|
Bortezomib SUN
Powder for solution for injection
Compare
|
EU/1/16/1102/001
Authorised: 22/07/2016
Sun Phamaceutical Industries Europe B.V.
|
SPC
PIL
IPAR
|
Bosentan Zentiva 125 mg film-coated tablets
Film-coated tablet
Compare
|
PA1701/011/002
Authorised: 23/02/2024
Zentiva k.s.
|
SPC
PIL
|
Bosentan Zentiva 62.5 mg film-coated tablets
Film-coated tablet
Compare
|
PA1701/011/001
Authorised: 23/02/2024
Zentiva k.s.
|
SPC
PIL
|
Bosulif
Film-coated tablet
Compare
|
EU/1/13/818/001-002
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
|
Bosulif
Film-coated tablet
Compare
|
EU/1/13/818/003-004
Authorised: 27/03/2013
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
|
BOSULIF
Film-coated tablet
Compare
|
EU/1/13/818/006-007
Authorised: 22/05/2018
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
|
Bosutinib Clonmel 100 mg film coated tablets
Film-coated tablet
Compare
|
PA0126/369/001
Authorised: 19/04/2024
Clonmel Healthcare Ltd
|
SPC
PIL
|
Bosutinib Clonmel 400 mg film coated tablets
Film-coated tablet
Compare
|
PA0126/369/002
Authorised: 19/04/2024
Clonmel Healthcare Ltd
|
SPC
PIL
|
Bosutinib Clonmel 500 mg film coated tablets
Film-coated tablet
Compare
|
PA0126/369/003
Authorised: 19/04/2024
Clonmel Healthcare Ltd
|
SPC
PIL
|
BOTOX 200 Allergan UnitsPowder for solution for injection
Powder for solution for injection
Compare
|
PA1824/017/003
Authorised: 18/01/2008
AbbVie Limited
|
SPC
PIL
IPAR
|
BOTOX 50 Allergan Units Powder for solution for injection
Powder for solution for injection
Compare
|
PA1824/017/002
Authorised: 18/01/2008
AbbVie Limited
|
SPC
PIL
IPAR
|
Botox100 Allergan Units Powder for solution for injection
Powder and solvent for solution for injection
Compare
|
PA1824/017/001
Authorised: 07/01/2000
AbbVie Limited
|
SPC
PIL
IPAR
|